|
NFYB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.774600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.332500E-02 |
| Normal-vs-Stage2 |
1.563800E-01 |
| Normal-vs-Stage3 |
8.951600E-01 |
| Normal-vs-Stage4 |
8.616800E-01 |
| Stage1-vs-Stage2 |
9.581400E-01 |
| Stage1-vs-Stage3 |
1.640830E-01 |
| Stage1-vs-Stage4 |
2.320000E-01 |
| Stage2-vs-Stage3 |
3.047600E-01 |
| Stage2-vs-Stage4 |
2.831000E-01 |
| Stage3-vs-Stage4 |
8.254800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.427000E-01 |
| Normal-vs-AfricanAmerican |
5.601000E-01 |
| Normal-vs-Asian |
4.850800E-01 |
| Caucasian-vs-AfricanAmerican |
5.146800E-01 |
| Caucasian-vs-Asian |
9.026600E-01 |
| AfricanAmerican-vs-Asian |
7.632400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.989160E-01 |
| Normal-vs-Female |
6.513400E-01 |
| Male-vs-Female |
2.656800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.349200E-01 |
| Normal-vs-Extreme_Weight |
6.915800E-02 |
| Normal-vs-Obese |
6.198200E-01 |
| Normal-vs-Extreme_Obese |
1.128450E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.737600E-01 |
| Normal_Weight-vs-Obese |
4.331200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.629210E-01 |
| Extreme_Weight-vs-Obese |
1.479440E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.671820E-01 |
| Obese-vs-Extreme_Obese |
6.126300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.510000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.524800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.072000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.225400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.371450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.900000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.340400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.735700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.890000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.536000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.883400E-01 |
| Normal-VS-Type2 PRCC |
4.523500E-03 |
| Normal-VS-KIRP CIMP |
1.522390E-01 |
| Normal-VS-Unclassified PRCC |
2.943800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.442840E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.114760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.274000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.191800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.022440E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.093900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.703500E-03 |
| Normal-vs-N1 |
2.139800E-01 |
| Normal-vs-N2 |
9.018800E-01 |
| N0-vs-N1 |
3.175900E-03 |
| N0-vs-N2 |
2.450400E-01 |
| N1-vs-N2 |
5.174600E-01 |
|
|
